A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
Registro de estudiosClinicalTrials.gov
Año 2013
A study to compare the change in cognitive performance and psychological status of patients with spasticity due to Multiple Sclerosis when treated with Sativex or placebo, added to existing anti-spasticity therapy over a period of 48 weeks. Secondary objectives were to evaluate the effect of Sativex on mood and spasticity and to assess the safety and tolerability of Sativex.
Epistemonikos ID: 594f0d7775092cb11aeb67e0ab478074d5c87275
First added on: Mar 31, 2022